Both private equity- and venture capital related IPO activity ticked up in the second quarter after a relatively quiet first quarter. Just more than half of the $2.8 billion in proceeds from the PE-backed IPOs related to two consumer sector holdings. Among the VC-backed IPOs, eight of the 12 were biotech offerings, and after taking a quarter off, the technology sector saw some life with three IPOs. VC-backed proceeds were decidedly smaller than their PE counterparts at $800 million.
